Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FENYA
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,591
Award facts
- Contract value 100% obligated
- $11,591.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $11,591.04 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order, issued on December 31, 2025 with an ultimate completion date of January 2, 2026, falls under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The broader PPV-G GEN V acquisition strategy, valued at $30.3 billion, establishes multiple regional prime vendor contractors to supply pharmaceutical products to Department of Defense healthcare facilities worldwide. This specific delivery order was issued without a set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement.
DMS Pharmaceutical Group's comprehensive product portfolio supports the delivery order through its established capabilities in distributing branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, specialty pharmaceuticals, and medical consumables to federal military healthcare operations. The contractor's IDC, awarded on November 13, 2025 with a ceiling value of $499,999,999 and completion date of December 31, 2036, comprises a 30-month base period with three 30-month option periods. As the sole awardee identified on this delivery order with no subcontractors involved, DMS Pharmaceutical Group serves as a critical supplier within the Department of Defense's pharmaceutical supply chain, with demonstrated substantial federal contracting activity through numerous prior delivery orders and purchase orders issued by the DLA's Medical Supply Chain division.
Quick answers
Who was awarded contract SPE2DU26FENYA?
SPE2DU26FENYA was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 31, 2025.
How much is contract SPE2DU26FENYA worth?
The government has obligated $11,591 on SPE2DU26FENYA.
Is contract SPE2DU26FENYA an order under another contract?
Yes. SPE2DU26FENYA is a delivery order under SPE2DU25D9418, an indefinite delivery contract.
Was contract SPE2DU26FENYA competed?
The extent of competition for SPE2DU26FENYA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award